Submitted by Anonymous (not verified) on 23 March 2026 - 15:41
Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 16, Status: Authorised
Source: